The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.
about
Adamantyl Antiestrogens with Novel Side Chains Reveal a Spectrum of Activities in Suppressing Estrogen Receptor Mediated Activities in Breast Cancer Cells.Novel Selective Estrogen Receptor Downregulators (SERDs) Developed against Treatment-Resistant Breast Cancer.Estrogen receptors in breast and bone: from virtue of remodeling to vileness of metastasis.The Evolving Role of the Estrogen Receptor Mutations in Endocrine Therapy-Resistant Breast Cancer.18F-Fluoroestradiol PET/CT Measurement of Estrogen Receptor Suppression during a Phase I Trial of the Novel Estrogen Receptor-Targeted Therapeutic GDC-0810: Using an Imaging Biomarker to Guide Drug Dosage in Subsequent Trials.Structurally Novel Antiestrogens Elicit Differential Responses from Constitutively Active Mutant Estrogen Receptors in Breast Cancer Cells and Tumors.A Computational Assay of Estrogen Receptor α Antagonists Reveals the Key Common Structural Traits of Drugs Effectively Fighting Refractory Breast Cancers.Are We Ready to Use ESR1 Mutations in Clinical Practice?Proteomic profiling identifies key coactivators utilized by mutant ERα proteins as potential new therapeutic targets.Specific stereochemistry of OP-1074 disrupts estrogen receptor alpha helix 12 and confers pure antiestrogenic activity.
P2860
Q38430208-5CA42AF1-48B1-458E-9DD6-62FA0EEBDEFBQ38719706-1F63407B-F9C7-41D7-9599-5C792B1A0F45Q39214999-CE9B523C-1C70-455C-84D3-9A8E415CD962Q39218132-6F0B1B02-D394-47EC-A568-3C84379E30E6Q40409656-1EF57D6C-445F-41E8-B61C-0C78AFF87B61Q47807006-6256D576-C885-4EFA-BBD5-A00EC72D8667Q49724900-0FAB7E98-0197-4BF0-B284-37EA22BCB67CQ49885951-E874A3C1-6FE4-468F-9A3D-22FA0981EB09Q53684285-CC267B3E-1F60-4EA9-9967-FE8CD8D61C62Q55242399-7FD88316-E473-4E10-8600-BD0461504B22
P2860
The selective estrogen receptor downregulator GDC-0810 is efficacious in diverse models of ER+ breast cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The selective estrogen recepto ...... e models of ER+ breast cancer.
@ast
The selective estrogen recepto ...... e models of ER+ breast cancer.
@en
The selective estrogen recepto ...... e models of ER+ breast cancer.
@nl
type
label
The selective estrogen recepto ...... e models of ER+ breast cancer.
@ast
The selective estrogen recepto ...... e models of ER+ breast cancer.
@en
The selective estrogen recepto ...... e models of ER+ breast cancer.
@nl
prefLabel
The selective estrogen recepto ...... e models of ER+ breast cancer.
@ast
The selective estrogen recepto ...... e models of ER+ breast cancer.
@en
The selective estrogen recepto ...... e models of ER+ breast cancer.
@nl
P2093
P2860
P356
P1433
P1476
The selective estrogen recepto ...... se models of ER+ breast cancer
@en
P2093
Alfonso Arrazate
Andiliy G Lai
Anna Aparicio
Beatrice Darimont
Benjamin Haley
Carlos L Arteaga
Celine Bonnefous
Dan Brigham
Deepak Sampath
P2860
P356
10.7554/ELIFE.15828
P407
P577
2016-07-13T00:00:00Z